NRC Health Increase (Decrease) in Deferred Charges
NRC Health (NRC) reported Increase (Decrease) in Deferred Charges of $433.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDeferredCharges · last filed 2026-08-04
- NRC Health increase (decrease) in deferred charges for the quarter ending 2026-06-30 was -$192.00K, a 648.57% decline year-over-year.
- NRC Health increase (decrease) in deferred charges for the quarter ending 2026-03-31 was $625.00K.
- NRC Health increase (decrease) in deferred charges for the quarter ending 2025-12-31 was $577.00K, a 79.75% increase year-over-year.
- NRC Health increase (decrease) in deferred charges for the quarter ending 2025-09-30 was $348.00K, a 673.33% increase year-over-year.
- NRC Health increase (decrease) in deferred charges for fiscal 2025 was $936.00K, a 758.72% increase from fiscal 2024.
- NRC Health increase (decrease) in deferred charges for fiscal 2024 was $109.00K.
- NRC Health increase (decrease) in deferred charges for fiscal 2023 was -$988.00K.
- NRC Health increase (decrease) in deferred charges for fiscal 2022 was -$1.33M.
| Period end | Increase (Decrease) in Deferred Charges 3 month | Increase (Decrease) in Deferred Charges 6 month | Increase (Decrease) in Deferred Charges 9 month | Increase (Decrease) in Deferred Charges 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$192.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $433.00K 10-Q · filed 2026-08-04 | $1.01M derived: sum of 3 quarters · filed 2026-08-04 | $1.36M derived: sum of 4 quarters · filed 2026-08-04 |
| 2026-03-31 | $625.00K 10-Q · filed 2026-05-06 | $1.20M derived: sum of 2 quarters · filed 2026-05-06 | $1.55M derived: sum of 3 quarters · filed 2026-05-06 | $1.58M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-12-31 | $577.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | $925.00K derived: sum of 2 quarters · filed 2026-03-05 | $960.00K derived: sum of 3 quarters · filed 2026-08-04 | $936.00K 10-K · filed 2026-03-05 |
| 2025-09-30 | $348.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $383.00K derived: sum of 2 quarters · filed 2026-08-04 | $359.00K 10-Q · filed 2025-11-07 | $680.00K derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-06-30 | $35.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $11.00K 10-Q · filed 2026-08-04 | $332.00K derived: sum of 3 quarters · filed 2026-08-04 | $377.00K derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-03-31 | -$24.00K 10-Q · filed 2026-05-06 | $297.00K derived: sum of 2 quarters · filed 2026-05-06 | $342.00K derived: sum of 3 quarters · filed 2026-05-06 | $284.00K derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | $321.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | $366.00K derived: sum of 2 quarters · filed 2026-03-05 | $308.00K derived: sum of 3 quarters · filed 2026-03-05 | $109.00K 10-K · filed 2026-03-05 |
| 2024-09-30 | $45.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | -$13.00K derived: sum of 2 quarters · filed 2025-11-07 | -$212.00K 10-Q · filed 2025-11-07 | -$400.00K derived: sum of 4 quarters · filed 2026-03-05 |
| 2024-06-30 | -$58.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08 | -$257.00K 10-Q · filed 2025-08-08 | -$445.00K derived: sum of 3 quarters · filed 2026-03-05 | -$748.00K derived: sum of 4 quarters · filed 2026-03-05 |
| 2024-03-31 | -$199.00K 10-Q · filed 2025-05-09 | -$387.00K derived: sum of 2 quarters · filed 2026-03-05 | -$690.00K derived: sum of 3 quarters · filed 2026-03-05 | -$981.00K derived: sum of 4 quarters · filed 2026-03-05 |
| 2023-12-31 | -$188.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | -$491.00K derived: sum of 2 quarters · filed 2026-03-05 | -$782.00K derived: sum of 3 quarters · filed 2026-03-05 | -$988.00K 10-K · filed 2026-03-05 |
| 2023-09-30 | -$303.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08 | -$594.00K derived: sum of 2 quarters · filed 2024-11-08 | -$800.00K 10-Q · filed 2024-11-08 | -$1.14M derived: sum of 4 quarters · filed 2025-03-17 |
| 2023-06-30 | -$291.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | -$497.00K 10-Q · filed 2024-08-08 | -$840.00K derived: sum of 3 quarters · filed 2025-03-17 | -$1.22M derived: sum of 4 quarters · filed 2025-03-17 |
| 2023-03-31 | -$206.00K 10-Q · filed 2024-05-09 | -$549.00K derived: sum of 2 quarters · filed 2025-03-17 | -$932.00K derived: sum of 3 quarters · filed 2025-03-17 | -$1.26M derived: sum of 4 quarters · filed 2025-03-17 |
| 2022-12-31 | -$343.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-17 | -$726.00K derived: sum of 2 quarters · filed 2025-03-17 | -$1.06M derived: sum of 3 quarters · filed 2025-03-17 | -$1.33M 10-K · filed 2025-03-17 |
| 2022-09-30 | -$383.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | -$714.00K derived: sum of 2 quarters · filed 2023-11-09 | -$988.00K 10-Q · filed 2023-11-09 | -$1.45M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-06-30 | -$331.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-04 | -$605.00K 10-Q · filed 2023-08-04 | -$1.07M derived: sum of 3 quarters · filed 2024-02-27 | -$1.48M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-03-31 | -$274.00K 10-Q · filed 2023-05-05 | -$739.00K derived: sum of 2 quarters · filed 2024-02-27 | -$1.14M derived: sum of 3 quarters · filed 2024-02-27 | -$1.33M derived: sum of 4 quarters · filed 2024-02-27 |
| 2021-12-31 | -$465.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | -$870.00K derived: sum of 2 quarters · filed 2024-02-27 | -$1.06M derived: sum of 3 quarters · filed 2024-02-27 | -$783.00K 10-K · filed 2024-02-27 |
| 2021-09-30 | -$405.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-04 | -$596.00K derived: sum of 2 quarters · filed 2022-11-04 | -$318.00K 10-Q · filed 2022-11-04 | -$306.00K derived: sum of 4 quarters · filed 2023-03-03 |
| 2021-06-30 | -$191.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-05 | $87.00K 10-Q · filed 2022-08-05 | $99.00K derived: sum of 3 quarters · filed 2023-03-03 | |
| 2021-03-31 | $278.00K 10-Q · filed 2022-05-06 | $290.00K derived: sum of 2 quarters · filed 2023-03-03 | ||
| 2020-12-31 | $12.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-03 | $351.00K 10-K · filed 2023-03-03 | ||
| 2020-09-30 | $339.00K 10-Q · filed 2021-11-05 | |||
| 2019-12-31 | $211.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-04 | $460.00K derived: sum of 2 quarters · filed 2022-03-04 | $561.00K derived: sum of 3 quarters · filed 2022-03-04 | $719.00K 10-K · filed 2022-03-04 |
| 2019-09-30 | $249.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08 | $350.00K derived: sum of 2 quarters · filed 2019-11-08 | $508.00K 10-Q · filed 2019-11-08 | $622.00K derived: sum of 4 quarters · filed 2020-03-06 |
| 2019-06-30 | $101.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | $259.00K 10-Q · filed 2019-08-08 | $373.00K derived: sum of 3 quarters · filed 2020-03-06 | $374.00K derived: sum of 4 quarters · filed 2020-03-06 |
| 2019-03-31 | $158.00K 10-Q · filed 2019-05-08 | $272.00K derived: sum of 2 quarters · filed 2020-03-06 | $273.00K derived: sum of 3 quarters · filed 2020-03-06 | $71.00K derived: sum of 4 quarters · filed 2020-03-06 |
| 2018-12-31 | $114.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-06 | $115.00K derived: sum of 2 quarters · filed 2020-03-06 | -$87.00K derived: sum of 3 quarters · filed 2020-03-06 | $113.00K 10-K · filed 2020-03-06 |
| 2018-09-30 | $1.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08 | -$201.00K derived: sum of 2 quarters · filed 2019-11-08 | -$1.00K 10-Q · filed 2019-11-08 | |
| 2018-06-30 | -$202.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | -$2.00K 10-Q · filed 2019-08-08 | ||
| 2018-03-31 | $200.00K 10-Q · filed 2019-05-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |